India's Antibiotic Crisis: A Call for Schedule X Classification
Is it time for India to place antibiotic medications under the stringent Schedule X of the Drugs and Cosmetics Act, 1945? This schedule currently governs the sale and distribution of highly addictive substances like ketamine, methamphetamine, and amphetamine, which are often linked to illegal narcotics. The proposal aims to curb the rampant misuse of antibiotics, which experts warn is fueling a devastating public health emergency.
Leading Voices on a Harsh but Necessary Measure
Dr. Nageshwar Reddy, a distinguished gastroenterologist and recipient of all three Padma awards, describes the potential move as "harsh but possibly the only solution" to stop Indians from consuming antibiotics indiscriminately. He co-authored a global study indicating that every third person could be affected by superbugs—bacteria resistant to antibiotics due to overuse. This resistance leads to prolonged illnesses, extended hospital stays, and exorbitant medical bills, depleting personal savings.
Disturbingly, the study found that resistant genes are being exchanged among organisms in the human gut, exacerbating the crisis. Currently, antibiotics fall under Schedule H1, which imposes penalties for over-the-counter sales but lacks the severe deterrents of Schedule X. Dr. Reddy emphasizes, "We need a law that permanently seals a shop if found selling antibiotics over the counter." He notes that even near his hospital in Hyderabad, chemists readily dispense antibiotics without prescriptions.
Alarming Proportions of Antimicrobial Resistance
Enforcement has been lax, making over-the-counter antibiotic sales a norm. Dr. Vinay Nandicoori, Director of CSIR-Centre for Cellular and Molecular Biology (CCMB), argues that strict implementation of existing laws is crucial, regardless of schedule changes. He advocates for a holistic approach: "Not only should antibiotics be given only with a prescription, but we also need to reduce usage in sectors like farming, fisheries, poultry, and dairy." Without action, India could face a major public health hazard by 2050.
The history of antibiotics reveals a shrinking gap between drug discovery and resistance. For instance:
- Penicillin, discovered in 1928, saw resistance by 1942.
- Streptomycin, discovered in 1943, faced resistance by 1946.
- By 2000, bacteria developed resistance to nearly all new antibiotics within a year.
This renders life-saving medicines ineffective and infections harder to treat. WHO data shows antimicrobial resistance (AMR) directly caused 1.27 million global deaths in 2019 and contributed to 4.95 million deaths. India is considered the epicenter, with AMR rates at one in three people, compared to one in six in Africa. Prime Minister Narendra Modi highlighted the need to reduce antibiotic use in his last Mann ki Baat of 2025.
Rising Burden and Global Impact
Superbugs often infect patients during hospital visits, but AMR is now prevalent in communities. Dr. Reddy warns of a "deadly triad": high resistance, high infection rates, and increased antibiotic costs leading to fatalities. Recent studies confirm India's central role in this global crisis:
- A Lancet study co-authored by Dr. Reddy found 83% of patients at AIG Hospital carried drug-resistant bacteria, based on data from 1,200 patients across the Netherlands, Italy, and the US.
- ICMR's 2024 AMRSN report used 100,000 samples to show common infections like urinary tract, pneumonia, sepsis, and diarrhea are becoming increasingly untreatable.
Key Strategies: Mapping, Pharmacovigilance, and Awareness
Experts urge mapping antibiotic use in communities and implementing pharmacovigilance—monitoring drug effects post-licensing. Internationally, governments track prescriptions to understand usage patterns. Dr. Reddy notes, "In the Netherlands, they know exactly the type of antibiotics prescribed in a region last year... We don't have the data and need it urgently." ICMR may require support from other agencies for comprehensive data collection.
Doctors must aid this effort, and medical shops need close monitoring. Dr. Nandicoori stresses widespread ignorance about AMR: "It is important to educate people and doctors. In many countries, antibiotics are prescribed only for bacterial infections, not viral ones." Colistin, a last-resort antibiotic, is increasingly used, raising fears of further resistance development.
India excels at policing narcotics but lags in antibiotic regulation. As Dr. Reddy concludes, "We need such controls for antibiotics as well to avert a disaster." The debate continues, but the urgency to act is clear to prevent a full-blown health catastrophe.
